North America is expected to account for a significant share of the blood derivative product market, driven by strong healthcare systems, increasing adoption of plasma-derived therapies, and growing investments in biotechnology. The region’s robust regulatory framework and expanding plasma collection capabilities are further contributing to the demand for blood derivative products.
Blood...
SPARK Website
عربي